We are live on ! Find out more
CBPO

China Biologic Products Holdings, Inc.
CBPO

Delisted

CBPO was delisted on the 20th of April, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of CBPO yet.

CBPO Hedge Fund Activity: Q2 2021 in Review

0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q2 2021, worth a combined $0 — down 100% from $1.74B a quarter earlier.

Sellers outnumbered buyers: 84 funds closed out of CBPO and 0 opened new positions — a net loss of 84 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was HHLR Advisors, exiting entirely with an estimated $351M sold.

  • 0 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q2 2021, down from 86 in Q1 2021.
  • Funds reported $0 of China Biologic Products Holdings, Inc. stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new China Biologic Products Holdings, Inc. positions in Q2 2021 and 84 closed out, a net change of -84 holders.
  • The largest China Biologic Products Holdings, Inc. seller in Q2 2021 was HHLR Advisors, an estimated $351M sold.

Based on aggregated 13F filings for Q2 2021.